Sampoerna Agro Tbk (SGRO)
Jakarta Exchange · Indonesia · prices in IDR · close of 23 Oct 2026
Key indicators
| Last close | IDR 4,250.00 |
|---|---|
| 52-week range | 2,220.00 – 7,850.00 |
| Return, 1 month / 3 months | −6.4% / +28.8% |
| Return, 1 year / 3 years | −15.6% / +167.6% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 64.6% |
| Worst drawdown (1 year) | -71.5% |
| Average daily value traded | 234.41M IDR |
| Dividend yield | 4.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sampoerna Agro Tbk is an Indonesian plantation company that grows oil palms and produces crude palm oil and palm kernel products. Its operations include plantations and processing mills, and it also runs a seed nursery business supplying planting material. The company's customers are mainly processors and traders in the edible oils and food ingredients trade, and its estates and mills are located in Indonesia, where the company is based.
On this site Sampoerna Agro Tbk appears as a stock on the Jakarta Exchange (Indonesia), code SGRO, with prices in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sampoerna Agro Tbk (SGRO) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 4,250.00 on 23 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 493 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.6% and over the last three months it rose 28.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -6.8% | ||
| From 52-week high | -45.9% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 28.8% | ||
| 6-month return | -17.1% | ||
| 12-month return, skipping the last month | -9.8% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 64.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -71.5% | ||
| Liquidity | 30 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 234.41M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.5% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +13.3% |
|---|---|
| 1 month | −6.4% |
| 3 months | +28.8% |
| 6 months | −17.1% |
| 1 year | −15.6% |
| 3 years | +167.6% |
| 5 years | +162.8% |
Signals
| 50-day / 200-day average | 4,533.70 / 4,562.41 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 270.00 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Jul 2026 | IDR 193.0000 |
| 22 May 2025 | IDR 330.0000 |
| 5 Jun 2024 | IDR 121.0000 |
| 20 Jun 2023 | IDR 198.0000 |
| 8 Jun 2022 | IDR 135.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.